Table 1 Abbreviations

UK Expert Consensus Statement for the Optimal Use and Clinical Utility of Leadless Pacing Systems on Behalf of the British Heart Rhythm Society. A UK expert panel used a modified Delphi method to assess how LPs can be better utilised. They developed 36 survey statements and distributed them to LP implanters. The consensus process required a 25% response rate and at least 75% of statements meeting a 66% agreement threshold. 31 statements reached consensus, with 23 gaining 90% and above agreement. Based on these results, seven recommendations were proposed to help expand LP use and improve population outcomes.

British Heart Rhythm Society Standards for Implantation and Follow-up of Cardiac Rhythm Management Devices in Adults: January 2024 Update. LP may be recommended for people at high risk of infection, those with end-stage renal disease, previous device infections, anatomical barriers to transvenous systems, immunocompromised population, those on biological or immunosuppressive therapies, or receiving radiotherapy near the device site. It may also be considered for people with congenital heart disease or those under 40 years of age, particularly when atrioventricular synchrony is clinically important.